Two Sigma Advisers’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-8,000
Closed -$837K 2144
2014
Q4
$837K Sell
8,000
-53,000
-87% -$5.59M 0.01% 1269
2014
Q3
$6.5M Sell
61,000
-95,000
-61% -$9.85M 0.05% 408
2014
Q2
$16.3M Sell
156,000
-179,000
-53% -$18.1M 0.13% 185
2014
Q1
$32.9M Buy
335,000
+40,200
+14% +$3.73M 0.3% 70
2013
Q4
$27M Sell
294,800
-100
-0% -$9.22K 0.26% 79
2013
Q3
$25.6M Buy
294,900
+203,900
+224% +$18.3M 0.3% 62
2013
Q2
$7.81M Buy
+91,000
New +$7.72M 0.11% 177

Other funds holding JNJ

Two Sigma Advisers's JNJ Position: Q1 2026 in Review

Two Sigma Advisers sold out of Johnson & Johnson (JNJ) in Q1 2026, closing a stake of 350,509 shares — an estimated $72.5M sold.

Two Sigma Advisers first reported a position in JNJ in Q3 2013 and held it in 49 quarters. The position peaked at $579M in Q3 2019. 4,615 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Two Sigma Advisers reported no remaining Johnson & Johnson position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 350,509 Johnson & Johnson shares in Q1 2026, an estimated $72.5M.
  • Two Sigma Advisers first reported a position in Johnson & Johnson in Q3 2013 and held it in 49 quarters.
  • Two Sigma Advisers's Johnson & Johnson position peaked at $579M in Q3 2019.
  • 4,615 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.